ERE Stock: price and insider trades · Australia

ERE is a Chemicals company. Its directors and officers file their transactions with ASX. The last twelve months, up to 18 October 2026, brought 2 filings signed by 2 insiders.

Only purchases show up on the open market, 2 purchases in all worth €41k, filed by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €33k, bought by Thomas Mann and made public on 12 May 2026 (0.60% of market cap). On the buying side, the filings list 2 senior executives among the declarants.

The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (17 May 2026) now reads 153 days.

For context, the typical company on the same exchange (median of 2,530 companies) published 3 filings over the same period, against 2 filings here. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.

For comparison within the same sector, see the insider buying recorded at Culp Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.